🧬 Noam Solomon - Immunai - Part 2 | The Value of Attending Prestigious Institutions | Immunai’s Genesis | AI, Machine Learning, & Their Applications in the Life Sciences | Mapping the Human Immune System

The Biotech Startups Podcast

Part 2 of 4.

My guest for this week’s episode is Noam Solomon, CEO and co-founder at Immunai, a pioneering biotech company that is comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development, and improve patient outcomes.

Prior to co-founding Immunai, Noam had a career in both industry and academia. Noam has a double PhD in math and computer science and served as a postdoctoral researcher at MIT and Harvard. Noam also worked as an algorithms developer, consultant, and head of data science in several high-tech companies in Israel. Noam's extensive background in math, computer science, AI, and machine learning gives him a unique depth of experience that founders can learn from.

Join us this week and hear about:

• The impact of attending prestigious institutions like Harvard and MIT on his career and networking opportunities
• The genesis of Immunai, inspired by personal experiences and focused on precision medicine in cancer treatment
• Explaining AI and Machine Learning, their distinctions, and the current state of AI in biology and drug development
• The complexity of the immune system and Immunai's ambitious goal to map it completely
• The convergence of technological advancements (single-cell technology, computing power, and AI models) that created the "perfect storm" for founding Immunai
  

Please enjoy my conversation with Noam Solomon.

Timestamps:

00:28 Intro

02:00 Episode starts, Noam’s decision to pursue postdoctoral studies at Harvard and MIT

03:31 The value of pedigree and superficial evaluations in business

04:33 Moving to Boston and the cultural experience at Harvard and MIT

06:47 Humility in mathematics and the inspiration from academic environments

08:19 Incubation of Immunai and the motivation behind its founding

11:41 The role of AI and ML in life sciences and common misconceptions

14:39 Progress in AI, ML, and their implications in drug development

18:46 Early days of Immunai and developing the technology platform

24:03 Mapping the human immune system and the complexity involved

25:05 Outro

Find Our Guest, Noam Solomon, at this link:

https://www.linkedin.com/in/noam-solomon-142393129/

https://www.immunai.com/

Find Our Host, Jon Chee, at these links:

https://www.linkedin.com/in/jonchee

https://www.excedr.com

Social & Website

LinkedIn: https://www.linkedin.com/company/excedr/

Youtube: https://www.youtube.com/@excedr

Instagram: https://www.instagram.com/excedr_inc

Twitter: https://twitter.com/ExcedrInc

Facebook: https://www.facebook.com/excedr

TikTok: https://www.tiktok.com/@excedr

Podcast Website: https://www.thebiotechstartupspodcast.com/

Enriched Notes:

Topics Mentioned:

MIT https://www.mit.edu/

Harvard University https://www.harvard.edu/

Immunai https://www.immunai.com/

What Is Bioinformatics https://www.excedr.com/blog/what-is-bioinformatics-and-computational-biology

New Drug Application https://www.excedr.com/blog/new-drug-application-process

Guide to the FDA Drug Approval Process https://www.excedr.com/blog/fda-drug-approval-process-guide

Equipment Leasing for Laboratories https://www.excedr.com/leasing

Biotech Startup Support https://www.excedr.com/resources-category/biotech-startup-support

The Biotech Startups Podcast is handcrafted by our friends over at: fame.so